JOHNS HOPKINS MEDICINE


Search

Black spacer

ABOUT JOHNS HOPKINS MEDICINE

HEALTH INFORMATION

PATIENT CARE

RESEARCH

EDUCATION

Hopkins Medicine Home Page

Department of Psychiatry & Behavioral Sciences

Dr. Sarah A. Reading

Dr. Chiadi U. Onyike

Dr. Akira Sawa

Email This Link
Print This Page
     
   

Psychiatry HOME

About Us
Support Us
Contact Us

INFORMATION FOR

Patients and Families
Faculty and Staff 
Health Professionals

Medical Students, 
Residents, Fellows

INFORMATION ABOUT
Admissions
Clinical Services
Faculty Directory
Media Coverage 
Nursing
Publications
Research
Search this site:

RESEARCH VOLUNTEERS NEEDED
Click here for studies currently recruiting patients

Psychiatry
E-NEWS UPDATE
Sign up to stay in touch with department news, events, and research.  

vertical rule

logo Fall 2006
 Volume 2, Number 2



News from the Johns Hopkins Department of Psychiatry and Behavioral Sciences

TRANSLATIONS: Way to Go

James Potash

As it begins to sink in that “chronic” is a true variety of major depression, don’t expect dramatic change in the way we treat patients, says psychiatrist James Potash, senior researcher on the Hopkins team (see left) that teased the finding from a larger study.

“It ultimately helps patients to have more realistic expectations,” he adds, “and we remind them of the Hopkins dictum for chronic depression: We aim for you to be 80 percent well 80 percent of the time.”

But at this early point, the study’s benefits come more as signposts for research. With a “pure” group of chronically depressed patients, says Potash, we’re now better able to describe their illness and see what we don’t know.

“They’re people swimming below the surface,” he says, citing a colleague’s description. “At times they plunge deep down. At others, they’re only inches away from the top. What they have, then, is chronic low-grade depression—dysthymia—with major depression superimposed. Both, we think, are versions of the same thing.” But are they? And what causes the plunge? Is it stress? Genes? An unfortunate mix? Some patients are resistant to antidepressants—are the chronically depressed more often in that group?

Finding which gene or genes make depression chronic is the step that would lead to answers for hovering questions, as well as suggest new targets for therapy, Potash says. One gene search is under way—GenRED II—at Hopkins and nationally. The first GenRED sought the broad chromosomal areas likely to harbor depression genes. It kindly uncovered just such a “neighborhood” on chromosome 15. Now with GenRED II about to screen several thousand patients, “we hope to return there,” Potash says, “and, in effect, go door to door to pick out specific genes.” New-generation gene chips that can scan up to 500,000 variable sites in a patient’s DNA “give us a gene-hunting power we never dreamed of.” 


Return to other articles in this issue.

Find other Hopkins Brain Wise Newsletter articles from past issues.




  



 

AddThis Social Bookmark Button .
 .

FAQs | Maps & Directions | Privacy | Intranet | Contact JHM | Media Inquiries | Fund For JHM | Science Calendar

JOHNS HOPKINS HOSPITAL AND HEALTH SYSTEM
JOHNS HOPKINS UNIVERSITY
JOHNS HOPKINS MEDICINE

.

U.S.News & World Report - Best Hospital

U.S.News and World Report - Best Grad Schools

ANCC Magnet Recognition

 
 © The Johns Hopkins University, The Johns Hopkins Hospital and Johns Hopkins Health System, All rights reserved